Osaic Holdings’s Traws Pharma TRAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-8
Closed -$9 – 8107
2025
Q4
$9 Buy
+8
New +$18 ﹤0.01% 7765
2024
Q3
– Sell
-12
Closed -$137 – 7575
2024
Q2
$137 Buy
+12
New +$193 ﹤0.01% 7210
2024
Q1
– Hold
0
– – – 7146
2023
Q4
– Sell
-40
Closed -$681 – 7265
2023
Q3
$714 Hold
40
– – ﹤0.01% 6918
2023
Q2
$1.18K Hold
40
– – ﹤0.01% 6834
2023
Q1
$734 Buy
+40
New +$865 ﹤0.01% 7051
2022
Q4
– Hold
0
– – – 7461
2022
Q3
– Hold
0
– – – 7551
2022
Q2
– Hold
0
– – – 7641
2022
Q1
– Hold
0
– – – 7548
2021
Q4
– Hold
0
– – – 7609
2021
Q3
– Hold
0
– – – 7344
2021
Q2
– Hold
0
– – – 7153
2021
Q1
– Hold
0
– – – 6968
2020
Q4
– Hold
0
– – – 6608
2020
Q3
– Hold
0
– – – 6442
2020
Q2
– Hold
0
– – – 6370
2020
Q1
– Hold
0
– – – 6208

Other funds holding TRAW

Osaic Holdings's TRAW Position: Q1 2026 in Review

Osaic Holdings sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 8 shares — an estimated $9 sold.

Osaic Holdings first reported a position in TRAW in Q1 2023 and held it in 5 quarters. The position peaked at $1.18K in Q2 2023. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Osaic Holdings reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 8 Traws Pharma shares in Q1 2026, an estimated $9.
  • Osaic Holdings first reported a position in Traws Pharma in Q1 2023 and held it in 5 quarters.
  • Osaic Holdings's Traws Pharma position peaked at $1.18K in Q2 2023.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.